Oneness Biotech (4743.TWO) Earnings Analysis
Oneness Biotech (4743.TWO) has no confirmed upcoming earnings date. Last quarter (2026-03-05) it beat with EPS -0.0732 TWD vs -0.28 TWD est (+73.9%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E -22.28.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 4743.TWO next report earnings?
No confirmed upcoming earnings date is currently scheduled for 4743.TWO. This page updates as the calendar is published.
4743.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-05 | -0.0732 TWD | -0.28 TWD | +73.9% | Beat |
| 2025-11-10 | -0.00694 TWD | -0.41 TWD | +98.3% | Beat |
| 2025-05-12 | -0.34 TWD | -0.49 TWD | +30.6% | Beat |
| 2025-02-26 | -0.82 TWD | -0.56 TWD | -46.4% | Miss |
| 2024-11-11 | -1.06 TWD | -0.38 TWD | -178.9% | Miss |
| 2024-08-12 | -0.34527 TWD | 0.2286 TWD | -251% | Miss |
Beat rate: 3/6 (50%) over reported quarters with consensus data.
4743.TWO valuation and analyst view
| Trailing P/E | -22.28 |
|---|---|
| Trailing EPS | -2.12596 TWD |
| Price / book | 2.32 |
| Dividend yield | 0.00% |
| Market cap | 22.87B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Oneness Biotech (4743.TWO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 4743.TWO. This page updates as the calendar is published.
Did 4743.TWO beat earnings last quarter?
In its 2026-03-05 report, 4743.TWO posted EPS of -0.0732 TWD versus a -0.28 TWD estimate — a beat of 73.9%.
What is 4743.TWO's earnings track record?
Over the last 6 reported quarters with consensus data, 4743.TWO beat estimates 3 times (50%).
What is 4743.TWO's current P/E ratio and EPS?
4743.TWO trades at a trailing P/E of -22.28 on trailing EPS of -2.1259615345041176 TWD.
What do analysts rate 4743.TWO?
4743.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.